Literature DB >> 25855591

The association between thyroid autoantibodies in serum and abnormal function and structure of the thyroid.

Yue-Rong Yan1, Xi-Lian Gao2, Jing Zeng1, Yang Liu3, Qing-Guo Lv1, Jing Jiang2, Hui Huang4, Nan-Wei Tong1.   

Abstract

OBJECTIVES: To evaluate the association between thyroid autoantibodies and abnormalities in thyroid function and structure, and to investigate any risk factors.
METHODS: A cross-sectional survey was undertaken in Chengdu residents ≥ 18 years with no previous thyroid disease. The study participants provided demographic and clinical data. Thyroid function and serum concentrations of the thyroid autoantibodies antithyroperoxidase antibody (TPOAb) and antithyroglobulin antibody (TgAb) were measured.
RESULTS: A total of 1334 subjects were included in this study. The prevalence of TPOAb and TgAb positivity was significantly higher in female than in male subjects. The prevalence of thyroid autoantibodies in those with subclinical hypothyroidism and clinical hyper- and hypothyroidism was significantly greater than in euthyroid subjects. The concentration of TPOAb and TgAb in subjects with both TPOAb and TgAb was significantly higher than in those who exhibited only one type of thyroid autoantibody. Using multivariate logistic regression analysis, female sex, thyroid volume, thyroid hypo- and heteroechogenicity were found to be risk factors for the presence of autoantibodies.
CONCLUSIONS: Thyroid autoantibodies were common in the general population. Women with thyroid enlargement, hypoechogenicity and heteroechogenicity might benefit from routine screening for thyroid autoantibodies and thyroid function.
© The Author(s) 2015 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav.

Entities:  

Keywords:  Antithyroperoxidase antibody; antithyroglobulin antibody; epidemiology study; risk factors; thyroid autoantibodies; thyroid diseases

Mesh:

Substances:

Year:  2015        PMID: 25855591     DOI: 10.1177/0300060514562487

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  6 in total

1.  Seronegative phenotype in a pediatric population with Hashimoto's thyroiditis.

Authors:  Caterina Rizzardi; Roberto Franceschi; Vittoria Cauvin; Maria Bellizzi; Alice Liguori; Silvia Longhi; Fiorenzo Lupi; Massimo Soffiati; Giorgio Radetti
Journal:  Hormones (Athens)       Date:  2022-04-04       Impact factor: 2.885

2.  Incidence of thyroid dysfunction in an Iranian adult population: the predictor role of thyroid autoantibodies: results from a prospective population-based cohort study.

Authors:  Ashraf Aminorroaya; Rokhsareh Meamar; Massoud Amini; Awat Feizi; Azamosadat Tabatabae; Elham Faghih Imani
Journal:  Eur J Med Res       Date:  2017-06-21       Impact factor: 2.175

3.  Iodine nutritional status, the prevalence of thyroid goiter and nodules in rural and urban residents: a cross-sectional study from Guangzhou, China.

Authors:  Yuerong Yan; Lili You; Xiaoyi Wang; Zhuo Zhang; Feng Li; Hongshi Wu; Muchao Wu; Jin Zhang; Jiayun Wu; Caixia Chen; Xiaohui Li; Biwen Xia; Mingtong Xu; Li Yan
Journal:  Endocr Connect       Date:  2021-11-29       Impact factor: 3.335

4.  Is Waist-height Ratio Associated with Thyroid Antibody Levels in Children with Obesity?

Authors:  Bahar Özcabı; Gürkan Tarçın; Esma Şengenç; Feride Tahmiscioğlu Bucak; Oya Ercan; İbrahim Murat Bolayırlı; Olcay Evliyaoğlu
Journal:  J Clin Res Pediatr Endocrinol       Date:  2020-10-02

5.  Dynamic Changes in Antithyroperoxidase and Antithyroglobulin Antibodies Suggest an Increased Risk for Abnormal Thyrotropin Levels.

Authors:  Yongze Li; Di Teng; Haixia Guan; Yushu Li; Xiaochun Teng; Xiaohui Yu; Jinyuan Mao; Xiaoguang Shi; Chenling Fan; Zhongyan Shan; Weiping Teng
Journal:  Front Endocrinol (Lausanne)       Date:  2020-08-04       Impact factor: 5.555

6.  Long non‑coding RNA expression profiles identify lncRNA‑XLOC_I2_006631 as a potential novel blood biomarker for Hashimoto's thyroiditis.

Authors:  Huiyong Peng; Si Xiong; Xiangmei Ding; Xinyi Tang; Xuehua Wang; Li Wang; Yingzhao Liu
Journal:  Int J Mol Med       Date:  2020-10-13       Impact factor: 4.101

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.